Latest News Releases
Tranzyme Pharma and Norgine Sign License Agreement for Late-Stage Development Product, Ulimorelin (TZP-101), in Europe and Other Select Regions
Companies to Jointly Initiate Pivotal Phase 3 Studies in 2010 More...
view all news releases